Retrophin Inc. (RTRX)

21.39
0.17 0.80
NASDAQ : Health Technology
Prev Close 21.22
Open 21.18
Day Low/High 21.02 / 21.41
52 Wk Low/High 17.53 / 33.00
Volume 355.98K
Avg Volume 417.80K
Exchange NASDAQ
Shares Outstanding 41.44M
Market Cap 872.71M
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Week Of May 17th Options Trading For Retrophin (RTRX)

First Week Of May 17th Options Trading For Retrophin (RTRX)

Investors in Retrophin, Inc. saw new options begin trading this week, for the May 17th expiration.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANIK, EHTH, ENV, FUSB, IBP, NBEV, OXSQ, PK, SWM, THRM, XRX Downgrades: BRK.A, CENTA, EVH, KNSL, PAAS, PLAB, RTRX, TGP Initiations: CASA Read on to get TheStreet Quant Ratings' detailed report:

First Week Of RTRX September 20th Options Trading

First Week Of RTRX September 20th Options Trading

Investors in Retrophin, Inc. saw new options begin trading this week, for the September 20th expiration.

Interesting RTRX Put Options For November 16th

Interesting RTRX Put Options For November 16th

Investors in Retrophin, Inc. saw new options begin trading this week, for the November 16th expiration.

Robbins Arroyo LLP Is Investigating The Officers And Directors Of Retrophin, Inc. (RTRX) On Behalf Of Shareholders

Robbins Arroyo LLP Is Investigating The Officers And Directors Of Retrophin, Inc. (RTRX) On Behalf Of Shareholders

Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Retrophin, Inc.

First Week Of August 17th Options Trading For Retrophin (RTRX)

First Week Of August 17th Options Trading For Retrophin (RTRX)

Investors in Retrophin, Inc. saw new options begin trading this week, for the August 17th expiration.

Commit To Buy Retrophin At $12.50, Earn 6.4% Annualized Using Options

Investors eyeing a purchase of Retrophin, Inc. shares, but tentative about paying the going market price of $21.42/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Notable Two Hundred Day Moving Average Cross - RTRX

Notable Two Hundred Day Moving Average Cross - RTRX

In trading on Monday, shares of Retrophin, Inc. crossed below their 200 day moving average of $22.55, changing hands as low as $22.50 per share.

Retrophin Provides Corporate Update And 2018 Outlook

Retrophin Provides Corporate Update And 2018 Outlook

Preliminary full-year 2017 revenue of approximately $155 million

Retrophin Announces Presentation Of New Data From Physician-Initiated Treatment With Fosmetpantotenate At The Child Neurology Society's 26th Annual Meeting

Retrophin Announces Presentation Of New Data From Physician-Initiated Treatment With Fosmetpantotenate At The Child Neurology Society's 26th Annual Meeting

Patient with PKAN showed persistent improvement in function over 30-month period of treatment with fosmetpantotenate

Martin Shkreli Was Just Convicted on 3 Counts of Securities Fraud

Martin Shkreli Was Just Convicted on 3 Counts of Securities Fraud

"Pharma bro" Martin Shkreli was found guilty on three of eight counts of securities fraud.

TheStreet Quant Rating: D+ (Sell)